Bracanat (Olaparib 150 mg Tablets) – Targeted Therapy for Cancer Treatment Brand: Bracanat Generic Name: Olaparib Strength: 150 mg Form: Oral Tablets Manufacturer: Natco Pharma Availability: In Stock | Ships Worldwide Exported by: Unnati Pharmax Product Overview Bracanat (Olaparib 150 mg Tablets) is an advanced targeted therapy used in the treatment of ovarian, breast, prostate, and pancreatic cancers associated with BRCA gene mutations. Clinically equivalent to the global brand Lynparza, Bracanat belongs to a class of drugs called PARP inhibitors, which help block cancer cell repair and slow tumor progression. By selectively targeting cancer cells while sparing most healthy cells, Bracanat has become a preferred choice for oncologists worldwide, offering patients a powerful and convenient oral treatment option. Why Choose Bracanat (Olaparib 150 mg)? ✅ Trusted generic alternative to Lynparza at an affordable cost ✅ Clinically proven efficacy in BRCA-mutated cancers ✅ Convenient oral tablets for at-home cancer management ✅ Widely prescribed for ovarian, breast, prostate, and pancreatic cancers ✅ Manufactured under strict international quality standards How It Works Olaparib is a Poly (ADP-ribose) polymerase (PARP) inhibitor. PARP enzymes are involved in repairing damaged DNA in cells. By blocking PARP activity, Bracanat prevents cancer cells from repairing themselves, leading to their death while minimizing harm to normal cells. This mechanism makes Bracanat particularly effective in patients with BRCA1/BRCA2 mutations, where DNA repair pathways are already compromised. Composition Each film-coated tablet contains: Olaparib 150 mg Dosage and Administration The recommended dose is 150 mg tablets, taken twice daily, as prescribed by your oncologist. Duration of therapy depends on the type of cancer, prior treatments, and individual patient profile. Buy Bracanat (Olaparib 150 mg Tablets) Online Looking for affordable cancer treatment online? Order Bracanat Tablets from Unnati Pharmax, your trusted global exporter of high-quality oncology medicines. We ensure: ✅ 100% authentic medicines from authorized manufacturers ✅ Fast and reliable worldwide delivery ✅ Secure packaging with patient confidentiality ✅ Competitive pricing for bulk and individual requirements FAQs – Bracanat (Olaparib 150 mg Tablets) Q1: Is Bracanat the same as Lynparza? A1: Yes. Bracanat is the generic version of Lynparza, containing Olaparib 150 mg, offering the same therapeutic results at a lower price. Q2: Which cancers can Bracanat treat? A2: Bracanat is effective in treating ovarian, breast, prostate, and pancreatic cancers, especially in patients with BRCA mutations. Q3: How is Bracanat taken? A3: Bracanat is an oral tablet, usually taken twice daily, allowing convenient at-home treatment.